Rob B. van der Luijt

14.9k total citations
64 papers, 2.7k citations indexed

About

Rob B. van der Luijt is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Rob B. van der Luijt has authored 64 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 22 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Rob B. van der Luijt's work include Neuroendocrine Tumor Research Advances (15 papers), Cancer, Hypoxia, and Metabolism (13 papers) and BRCA gene mutations in cancer (11 papers). Rob B. van der Luijt is often cited by papers focused on Neuroendocrine Tumor Research Advances (15 papers), Cancer, Hypoxia, and Metabolism (13 papers) and BRCA gene mutations in cancer (11 papers). Rob B. van der Luijt collaborates with scholars based in Netherlands, United States and Germany. Rob B. van der Luijt's co-authors include Riccardo Fodde, Hans F. A. Vasen, Carli M.J. Tops, Cor Breukel, P. Meera Khan, Gerlof D. Valk, Cornelis J.M. Lips, Menno R. Vriens, Carolina R C Pieterman and P. J. van Diest and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Rob B. van der Luijt

63 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob B. van der Luijt Netherlands 28 931 804 802 782 595 64 2.7k
Patrick Treseler United States 31 870 0.9× 1.3k 1.6× 524 0.7× 475 0.6× 252 0.4× 66 3.4k
Frederik J. Hes Netherlands 38 1.3k 1.4× 1.8k 2.3× 1.2k 1.5× 1.7k 2.2× 231 0.4× 136 4.1k
Daniela Furlan Italy 30 1.5k 1.6× 1.1k 1.3× 850 1.1× 737 0.9× 630 1.1× 93 2.8k
António E. Pinto Portugal 24 742 0.8× 506 0.6× 707 0.9× 345 0.4× 182 0.3× 74 2.4k
Sophie Giraud France 28 446 0.5× 195 0.2× 889 1.1× 458 0.6× 508 0.9× 71 2.4k
Zhengping Zhuang United States 24 691 0.7× 394 0.5× 420 0.5× 346 0.4× 444 0.7× 33 1.7k
Lorenza Pecciarini Italy 17 860 0.9× 507 0.6× 836 1.0× 349 0.4× 156 0.3× 42 2.1k
Carli M.J. Tops Netherlands 35 1.4k 1.5× 2.3k 2.9× 891 1.1× 1.3k 1.7× 137 0.2× 93 3.3k
Ian M. Frayling United Kingdom 31 1.4k 1.6× 1.9k 2.4× 998 1.2× 789 1.0× 208 0.3× 72 3.3k
Irina A. Lubensky United States 26 635 0.7× 156 0.2× 1.1k 1.3× 652 0.8× 524 0.9× 41 2.2k

Countries citing papers authored by Rob B. van der Luijt

Since Specialization
Citations

This map shows the geographic impact of Rob B. van der Luijt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob B. van der Luijt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob B. van der Luijt more than expected).

Fields of papers citing papers by Rob B. van der Luijt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob B. van der Luijt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob B. van der Luijt. The network helps show where Rob B. van der Luijt may publish in the future.

Co-authorship network of co-authors of Rob B. van der Luijt

This figure shows the co-authorship network connecting the top 25 collaborators of Rob B. van der Luijt. A scholar is included among the top collaborators of Rob B. van der Luijt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob B. van der Luijt. Rob B. van der Luijt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermeulen, Marijn A., Rob B. van der Luijt, Carolien P. Schröder, John W.M. Martens, & P. J. van Diest. (2019). Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast. Journal of Clinical Pathology. 73(4). 204–208. 3 indexed citations
2.
Hout, Annemieke van der, Jan C. Oosterwijk, Janet R. Vos, et al.. (2018). The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?. European Journal of Human Genetics. 26(6). 848–857. 6 indexed citations
3.
Heemskerk-Gerritsen, B.A.M., Rob B. van der Luijt, Inge-Marie Obdeijn, et al.. (2014). Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy. Cancer Biology & Therapy. 15(4). 371–379. 5 indexed citations
4.
Pieterman, Carolina R C, Leonie T. van Hulsteijn, Martin den Heijer, et al.. (2012). Primary Hyperparathyroidism in MEN1 Patients. Annals of Surgery. 255(6). 1171–1178. 62 indexed citations
5.
Aaronson, Neil K., Frederik J. Hes, Thera P. Links, et al.. (2011). Compliance with periodic surveillance for Von-Hippel-Lindau disease. Genetics in Medicine. 13(6). 519–527. 12 indexed citations
6.
Wevers, Marijke R., Margreet G.E.M. Ausems, Senno Verhoef, et al.. (2011). Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial. BMC Cancer. 11(1). 6–6. 22 indexed citations
7.
Rump, Patrick, Jan D.H. Jongbloed, Birgit Sikkema‐Raddatz, et al.. (2011). Madelung deformity in a girl with a novel and de novo mutation in the GNAS gene. American Journal of Medical Genetics Part A. 155(10). 2566–2570. 4 indexed citations
8.
Luijt, Rob B. van der, Ellen van Rooijen, A M van den Ouweland, et al.. (2010). Genetic analysis of von Hippel-Lindau disease. Human Mutation. 31(5). n/a–n/a. 202 indexed citations
9.
Verhoef, Senno, Frederik J. Hes, Daniëlle Majoor‐Krakauer, et al.. (2010). Psychosocial impact of Von Hippel–Lindau disease: levels and sources of distress. Clinical Genetics. 77(5). 483–491. 32 indexed citations
10.
11.
Pieterman, Carolina R C, Jennifer M. J. Schreinemakers, H. P. F. Koppeschaar, et al.. (2008). Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clinical Endocrinology. 70(4). 575–581. 81 indexed citations
12.
13.
Lips, Cornelis J.M., et al.. (2004). Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines. Journal of Internal Medicine. 257(1). 69–77. 20 indexed citations
14.
Rijnders, R. J. P., Rob B. van der Luijt, Edith Peters, et al.. (2003). Earliest gestational age for fetal sexing in cell‐free maternal plasma. Prenatal Diagnosis. 23(13). 1042–1044. 74 indexed citations
15.
Hes, Frederik J., et al.. (2002). [From gene to disease; Von Hippel-Lindau disease].. PubMed. 146(29). 1364–7. 1 indexed citations
16.
Dreijerink, Koen M.A., et al.. (2000). [Multiple endocrine neoplasia type 1: recent developments and guidelines for DNA diagnosis and periodic clinical monitoring].. PubMed. 144(51). 2445–9. 1 indexed citations
17.
Eccles, Diana, Rob B. van der Luijt, Cor Breukel, et al.. (1996). Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene.. PubMed. 59(6). 1193–201. 138 indexed citations
18.
Luijt, Rob B. van der, P. Meera Khan, Hans F. A. Vasen, et al.. (1994). Rapid Detection of Translation-Terminating Mutations at the Adenomatous Polyposis Coli (APC) Gene by Direct Protein Truncation Test. Genomics. 20(1). 1–4. 171 indexed citations
19.
Tops, Carli M.J., Heleen M. van der Klift, Rob B. van der Luijt, et al.. (1993). Non‐allelic heterogeneity of familial adenomatous polyposis. American Journal of Medical Genetics. 47(4). 563–567. 25 indexed citations
20.
Fodde, Riccardo, Rob B. van der Luijt, Juul Wijnen, et al.. (1992). Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis. Genomics. 13(4). 1162–1168. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Treseler Breakdown of academic impact, for papers by Frederik J. Hes Breakdown of academic impact, for papers by Daniela Furlan Breakdown of academic impact, for papers by António E. Pinto Breakdown of academic impact, for papers by Sophie Giraud Breakdown of academic impact, for papers by Zhengping Zhuang Breakdown of academic impact, for papers by Lorenza Pecciarini Breakdown of academic impact, for papers by Carli M.J. Tops Breakdown of academic impact, for papers by Ian M. Frayling Breakdown of academic impact, for papers by Irina A. Lubensky
Rankless by CCL
2026